PAPER Lee K, Mahmud M, Marx D, Yasen W, Sharma O, Ivanidze J, Zan E, Zhou L, Li Y, de Leon MJ, Nordvig AS, Chiang GC

Clinical Arterial Spin-Labeling MR Imaging to Screen for Typical and Atypical Neurodegenerative Disease in the New Era of Alzheimer Treatment.

AJNR Am J Neuroradiol. 2024 May 9;45(5):632-636. PubMed.

PAPER Karim HT

Chasing Causality: Understanding the Link Between Benzodiazepine Exposure and Dementia Risk.

Am J Geriatr Psychiatry. 2024 Jun;32(6):678-680. Epub 2024 Mar 2 PubMed.

PAPER Kang YJ, Hyeon SJ, McQuade A, Lim J, Baek SH, Diep YN, Do KV, Jeon Y, Jo DG, Lee CJ, Blurton-Jones M, Ryu H, Cho H

Neurotoxic Microglial Activation via IFNγ-Induced Nrf2 Reduction Exacerbating Alzheimer's Disease.

Adv Sci (Weinh). 2024 May;11(20):e2304357. Epub 2024 Mar 14 PubMed.

PAPER Hillerstrom H, Fisher R, Janicki MP, Chicoine B, Christian BT, Esbensen A, Esralew L, Fortea J, Hartley S, Hassenstab J, Keller SM, Krinsky-McHale S, Lai F, Levin J, McCarron M, McDade E, Rebillat AS, Rosas HD, Silverman W, Strydom A, Zaman SH, Zetterberg H

Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndrome.

Alzheimers Dement. 2024 May;20(5):3649-3656. Epub 2024 Mar 13 PubMed.

PAPER Niu J, Zhong Y, Jin C, Cen P, Wang J, Cui C, Xue L, Cui X, Tian M, Zhang H

Positron Emission Tomography Imaging of Synaptic Dysfunction in Parkinson's Disease.

Neurosci Bull. 2024 Jun;40(6):743-758. Epub 2024 Mar 14 PubMed.

PAPER Wankhede NL, Kale MB, Umare MD, Lokhande S, Upaganlawar AB, Wal P, Taksande BG, Umekar MJ, Khandige PS, Singh B, Sadananda V, Ramniwas S, Behl T

Revisiting the Mitochondrial Function and Communication in Neurodegenerative Diseases.

Curr Pharm Des. 2024;30(12):902-911. PubMed.

PAPER Marques CR, Campos J, Sampaio-Marques B, Antunes FF, Dos Santos Cunha RM, Silva D, Barata-Antunes S, Lima R, Fernandes-Platzgummer A, da Silva CL, Sousa RA, Salgado AJ

Secretome of bone marrow mesenchymal stromal cells cultured in a dynamic system induces neuroprotection and modulates microglial responsiveness in an α-synuclein overexpression rat model.

Cytotherapy. 2024 Jul;26(7):700-713. Epub 2024 Feb 18 PubMed.

PAPER Plácido E, Koss DJ, Outeiro TF, Brocardo PS

Altered hippocampal doublecortin expression in Parkinson's disease.

J Neurochem. 2024 Aug;168(8):1514-1526. Epub 2024 Mar 14 PubMed.

PAPER Macedo AC, Therriault J, Tissot C, Fernandez-Arias J, Ferreira PC, Vitali P, Servaes S, Rahmouni N, Vermeiren M, Bezgin G, Lussier FZ, Stevenson J, Wang YT, Socualaya KQ, Kunach P, Nazneen T, Hosseini SA, Pallen V, Stevenson A, Ferrari-Souza JP, Bellaver B, Leffa DT, Ng KP, Zimmer ER, Pascoal TA, Gauthier S, Rosa-Neto P

Predicting functional decline in aging and Alzheimer's disease with PET-based Braak staging.

Brain Commun. 2024;6(2):fcae043. Epub 2024 Feb 26 PubMed.

PAPER Whitwell JL

Atypical clinical variants of Alzheimer's disease: are they really atypical?

Front Neurosci. 2024;18:1352822. Epub 2024 Feb 28 PubMed.

PAPER Frost CV, Schwierz N, Zacharias M

Efficient and accurate binding free energy calculation of Aβ9-40 protofilament propagation.

Proteins. 2024 Mar 14; PubMed.

PAPER Ranglani S, Hasan S, Komorowska J, Medina NM, Mahfooz K, Ashton A, Garcia-Ratés S, Greenfield S

A Novel Peptide Driving Neurodegeneration Appears Exclusively Linked to the α7 Nicotinic Acetylcholine Receptor.

Mol Neurobiol. 2024 Mar 14; PubMed.

PAPER Gu Y, Chen N, Zhu L, Chen X, Jiang T, Zhang Y

Whole Transcriptome Sequencing of Peripheral Blood Identifies the Alzheimer's Disease-Related circRNA-miRNA-lncRNA Pathway.

Curr Neurovasc Res. 2024;21(2):184-197. PubMed.

PAPER Martinelli F, Heinken A, Henning AK, Ulmer MA, Hensen T, González A, Arnold M, Asthana S, Budde K, Engelman CD, Estaki M, Grabe HJ, Heston MB, Johnson S, Kastenmüller G, Martino C, McDonald D, Rey FE, Kilimann I, Peters O, Wang X, Spruth EJ, Schneider A, Fliessbach K, Wiltfang J, Hansen N, Glanz W, Buerger K, Janowitz D, Laske C, Munk MH, Spottke A, Roy N, Nauck M, Teipel S, Knight R, Kaddurah-Daouk RF, Bendlin BB, Hertel J, Thiele I

Whole-body metabolic modelling reveals microbiome and genomic interactions on reduced urine formate levels in Alzheimer's disease.

Sci Rep. 2024 Mar 13;14(1):6095. PubMed. Correction.

John Contois

C2N Diagnostics
United States